The Advanced Certificate Program in
Lung Cancer Management III
  1. Curriculum III
  2. Curriculum II
  3. Curriculum I
  4. Full Course List

Currently Available

Course Title Curriculum Faculty Release Date
Expert Insight Into: Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer (Part 7 of Series) —Article Review (LC03.08) 1979.07 III Langer Jul 2010
Expert Insight Into: EGFR Tyrosine Kinase Inhibitor as Maintenance Therapy for Advanced NSCLC (Part 6 of Series)—Article Review (LC03.07) 1979.06 III Herbst Jun 2010
Case Study: EGFR Mutation Testing in a Never-Smoker with Advanced Stage NSCLC —Tx Reporter e-Newsletter (LC03.06) 1980 III Langer May 2010
Expert Insight Into: Maintenance Therapy Versus Placebo for NSCLC (Part 5 of Series)—Article Review (LC03.05) 1979.05 III Langer Apr 2010
Expert Insight Into:
Radiotherapy plus Chemotherapy With or Without Surgical Resection for Stage III NSCLC. (Part 4 of series)—Article Review (LC03.04) 1979.04		 III Herbst Apr 2010
Expert Insight Into: Clinical Features and Outcome of Patients with Non-Small-Cell Lung Cancer Who Harbor EML4-ALK (Part 3 of Series)—Article Review (LC03.03) 1979.03 III Langer Mar 2010
Expert Insight Into: EGFR Tyrosine Kinase Inhibitor or Combination Chemotherapy in Advanced Pulmonary Adenocarcinoma.
(Part 2 of Series)—Article Review (LC03.02) 1979.02		 III Herbst Feb 2010
Expert Insight Into: Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer (Part 1 of Series)—Article Review (LC03.01) 1979.01 III Langer Feb 2010

Coming Soon!

Course Title Curriculum Faculty Release Date
Case Study: Combined Modality Approach in Patients with Unresected/unresectable Stage III NSCLC and Good PS—Tx Reporter with Audio (LC03.09) 1980.02 III Curran Aug 2010
Expert Insight Into: First-Line TKI in Patients with Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR Mutations—Article Review (LC03.10) 1979.08 III Miller Sep 2010
Virtual Tumor Board—Podcast Series (LC03.11) 1986 III Herbst
Curran
Miller		 Sep 2010
Expert Insight Into: Primary Analysis of the Phase II Component of a Phase I/II Dose Intensification Study Using Three-Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients with Inoperable Non-Small-Cell Lung Cancer—Article Review (LC03.12) 1979.09 III Curran Oct 2010
Expert Insight Into: Novel Mutant-Selective EGFR Kinase Inhibitors Against EGFR T790M—Article Review (LC03.13) 1979.10 III Miller Nov 2010
Case Study: Advanced Non-Small Cell Lung Cancer with ELM4-ALK Fusion—Tx Reporter with Audio (LC03.14) 1980.03 III Miller Nov 2010